AltruBio   Report issue

For profit Phase 1 Phase 2
Founded: Los Altos CA United States (2000)

Organization Overview

First Clinical Trial
2011
NCT01466569
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

AbGenmics B.V. Taiwan Branch | AbGenomics B.V Taiwan Branch | AbGenomics International, Inc.